Telmisartan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-088 -
Package NDC
62332-088-30 -
Package NDC
62332-088-91 -
Application number
ANDA202130 -
SPL ID
a12a8f1f-5c6e-423d-97de-549bde6225a1 -
SPL set ID
c62d424c-7630-413c-be2c-3932831c3f1d -
UNII
U5SYW473RQ -
RxCUI
205304 -
RxCUI
205305 -
RxCUI
282755
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- Telmisartan
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Telmisartan",
"splId": "a12a8f1f-5c6e-423d-97de-549bde6225a1",
"labels": [
{
"setId": "c62d424c-7630-413c-be2c-3932831c3f1d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c62d424c-7630-413c-be2c-3932831c3f1d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c62d424c-7630-413c-be2c-3932831c3f1d"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (62332-088-30)",
"package_ndc": "62332-088-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20160625"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (62332-088-91)",
"package_ndc": "62332-088-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20160625"
}
],
"productId": "62332-088_a12a8f1f-5c6e-423d-97de-549bde6225a1",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "62332-088",
"deaSchedule": null,
"genericName": "Telmisartan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TELMISARTAN",
"strength": "40 mg/1"
}
],
"applicationNumber": "ANDA202130",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160625",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000070",
"N0000175561"
],
"upc": [
"0362332087303",
"0362332088300",
"0362332089307"
],
"unii": [
"U5SYW473RQ"
],
"rxcui": [
"205304",
"205305",
"282755"
],
"spl_set_id": [
"c62d424c-7630-413c-be2c-3932831c3f1d"
],
"pharm_class_epc": [
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-088_a12a8f1f-5c6e-423d-97de-549bde6225a1"